Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Adlai Nortye Ltd.
ANL | US
1.95
USD0
0%
ANL | US
About Adlai Nortye Ltd.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
1.95
Open
2.09
High
2.09
Low
1.95
View Less
ANL | US
Risk
62.3
Sharpe
-0.81
Luna's Score
40/100
Recommendation
Sell
Luna says (ANL | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
41.2%1 month
62.3%3 months
84.8%6 months
103.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.35
Debt to equity
0.73
Debt to assets
0.36
Ent. to EBITDA
-
Ent. to rev.
2.70
PEG
-
Other Fundamentals
EBITDA
-63.57M
MarketCap
71.96M
MarketCap(USD)
71.96M
Div. yield
-
Op. margin
-1.29K
Erngs. growth
-
Rev. growth
-
Ret. on equity
-
Short ratio
0.72
Short perc.
0.03
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.25
Range1M
0.42
Range3M
2.25
Volumes: Market Activity
Rel. volume
1.89
Price X volume
29.33K
